Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Connect with investors, share insights, and grow together
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning
A structured, comprehensive way to understand global investing
Read about our journey and get to know the leadership team at Vested
The fund employs a passive management - or indexing - investment approach designed to track the performance of the underlying index. It will normally invest at least 80% of its net assets in securities that comprise the underlying index. The underlying index is comprised of small and mid-cap stocks of biotechnology companies that have one or more drugs in either Phase II or Phase III of the U.S. Food and Drug Administration clinical trials. more
| Time Frame | SBIO | S&P500 |
|---|---|---|
| 1-Week Return | -0.98% | -2.26% |
| 1-Month Return | -8.59% | -0.27% |
| 3-Month Return | -2.62% | 8.83% |
| 6-Month Return | -0.57% | 7.2% |
| 1-Year Return | 59.07% | 22.24% |
| 3-Year Return | 52.74% | 69.99% |
| 5-Year Return | 1.73% | 74.03% |
| 10-Year Return | 106.21% | 251.74% |
| Time Frame | SBIO | S&P500 |
|---|---|---|
| 1-Week Return | -40.16% | -69.64% |
| 1-Month Return | -66.47% | -3.24% |
| 3-Month Return | -10.21% | 40.94% |
| 6-Month Return | -1.15% | 15.14% |
| 1-Year Return | 59.07% | 22.24% |
| 3-Year Return | 15.16% | 19.35% |
| 5-Year Return | 0.34% | 11.72% |
| 10-Year Return | 7.51% | 13.40% |
| Stock name | Ticker | Weight |
|---|---|---|
Alkermes PLC | ALKS | 4.78% |
Spyre Therapeutics Inc. | SYRE | 4.08% |
Kymera Therapeutics Inc. | KYMR | 4.03% |
Mirum Pharmaceuticals Inc. | MIRM | 3.69% |
Apogee Therapeutics Inc. | APGE | 3.37% |
CG oncology Inc. | CGON | 3.14% |
Xenon Pharmaceuticals Inc. | XENE | 2.92% |
Celcuity Inc. | CELC | 2.83% |
Travere Therapeutics Inc. | TVTX | 2.82% |
Edgewise Therapeutics Inc. | EWTX | 2.64% |
Newamsterdam Pharma Co. NV | NAMS | 2.49% |
Dianthus Therapeutics Inc. | DNTH | 2.48% |
ACADIA Pharmaceuticals Inc. | ACAD | 2.45% |
Crinetics Pharmaceuticals Inc. | CRNX | 2.4% |
Viking Therapeutics Inc. | VKTX | 2.28% |
Denali Therapeutics Inc. | DNLI | 2.11% |
Oruka Therapeutics Inc. | ORKA | 2% |
Structure Therapeutics Inc. | GPCR | 1.83% |
Disc Medicine Inc. | IRON | 1.8% |
Relay Therapeutics Inc. | RLAY | 1.72% |
Tarsus Pharmaceuticals Inc. | TARS | 1.7% |
Ideaya Biosciences Inc. | IDYA | 1.7% |
Vera Therapeutics Inc. | VERA | 1.58% |
Pharvaris NV | PHVS | 1.34% |
Celldex Therapeutics Inc. | CLDX | 1.32% |
Mineralys Therapeutics Inc. | MLYS | 1.31% |
Zai Lab Ltd. | ZLAB | 1.28% |
Lakefront Biotherapeutics NV | LKFT | 1.23% |
Vericel Corp. | VCEL | 1.2% |
Nuvation Bio Inc. | NUVB | 1.19% |
Rapport Therapeutics Inc. | RAPP | 1.19% |
Sarepta Therapeutics Inc. | SRPT | 1.16% |
Stoke Therapeutics Inc. | STOK | 1.14% |
Sionna Therapeutics Inc. | SION | 1.13% |
Agios Pharmaceuticals Inc. | AGIO | 1.12% |
Novavax Inc. | NVAX | 1.1% |
Taysha Gene Therapies Inc. | TSHA | 1.07% |
Amylyx Pharmaceuticals Inc. | AMLX | 1.05% |
Palvella Therapeutics Inc. | PVLA | 1.04% |
Tyra Biosciences Inc. | TYRA | 0.97% |
ArriVent Biopharma Inc. | AVBP | 0.97% |
Immunocore Holdings PLC | IMCR | 0.97% |
MBX Biosciences Inc. | MBX | 0.92% |
Immatics NV | IMTX | 0.9% |
KalVista Pharmaceuticals Inc. | KALV | 0.9% |
MoonLake Immunotherapeutics | MLTX | 0.89% |
Bicara Therapeutics Inc. | BCAX | 0.86% |
Maze Therapeutics Inc. | MAZE | 0.81% |
MannKind Corp. | MNKD | 0.72% |
Zenas Biopharma Inc. | ZBIO | 0.65% |
Corvus Pharmaceuticals Inc. | CRVS | 0.65% |
ARS Pharmaceuticals Inc. | SPRY | 0.6% |
Xencor Inc. | XNCR | 0.58% |
Olema Pharmaceuticals Inc. | OLMA | 0.56% |
Theravance Biopharma Inc. | TBPH | 0.55% |
Geron Corp. | GERN | 0.51% |
Kura Oncology Inc. | KURA | 0.51% |
Candel Therapeutics Inc. | CADL | 0.45% |
Oculis Holding AG | OCS | 0.45% |
Design Therapeutics Inc. | DSGN | 0.44% |
Alto Neuroscience Inc. | ANRO | 0.41% |
Fulgent Genetics Inc. | FLGT | 0.4% |
Aclaris Therapeutics Inc. | ACRS | 0.38% |
Rigel Pharmaceuticals Inc. | RIGL | 0.37% |
Tectonic Therapeutic Inc. | TECX | 0.36% |
Rezolute Inc. | RZLT | 0.29% |
Neurogene Inc. | NGNE | 0.28% |
Upstream Bio Inc. | UPB | 0.27% |
Compass Therapeutics Inc. | CMPX | 0.25% |
Altimmune Inc. | ALT | 0.25% |
Delcath Systems Inc. | DCTH | 0.25% |
Vanda Pharmaceuticals Inc. | VNDA | 0.24% |
REGENXBIO Inc. | RGNX | 0.24% |
Atea Pharmaceuticals Inc. | AVIR | 0.23% |
Zura Bio Ltd. | ZURA | 0.21% |
Anavex Life Sciences Corp. | AVXL | 0.17% |
Akebia Therapeutics Inc. | AKBA | 0.17% |
Protara Therapeutics Inc. | TARA | 0.16% |
Arcturus Therapeutics Holdings Inc. | ARCT | 0.15% |
Bicycle Therapeutics PLC | BCYC | 0.14% |
Forte Biosciences Inc. | FBRX | 0.14% |
Aardvark Therapeutics Inc. | AARD | 0.06% |
Cash Equivalent | USD | 0.04% |
Novo Nordisk A/S | Novo.Nordisk.A.S | 0% |
AstraZeneca PLC | AstraZeneca.PLC | 0% |
Chinook Therapeutics Inc. | Chinook.Therapeutics.Inc. | 0% |
| Sector | Weight |
|---|---|
|
Health care | 100.00% |
ALPS Medical Breakthroughs ETF (SBIO) share price today is $50.5209.
Yes, Indians can buy shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. To buy SBIO from India, you can open a US Brokerage account by signing up on Vested. The account opening process is completely digital and secure, and takes 3-5 minutes to complete.
Yes, you can purchase fractional shares of ALPS Medical Breakthroughs ETF (SBIO) on Vested. You can start investing in ALPS Medical Breakthroughs ETF (SBIO) with a minimum investment of $1.
The 52-week high price of ALPS Medical Breakthroughs ETF (SBIO) is $57.77. The 52-week low price of ALPS Medical Breakthroughs ETF (SBIO) is $29.33.
The stock symbol (or ticker) of ALPS Medical Breakthroughs ETF is SBIO.
Yes, you can setup SIP in ALPS Medical Breakthroughs ETF shares. Follow the below steps to create the SIP:
Here is the historical performance of SBIO on the Vested app.
The expense ratio of ALPS Medical Breakthroughs ETF (SBIO) is 0.5%.
Link copied